DIA 2013 49th Annual Meeting
Click here to go to the previous page
Cooperation Among Regulators: Impact on Stakeholders
Track : Track 10: Public Policy/ Health Care Compliance/ Law
Program Code: 135
Date: Monday, June 24, 2013
Time: 2:30 PM to 4:00 PM  EST
Location: 254AB
CHAIR (S):
 Marie Allison Dray, MA,MBA (SCHNON), President, International Regulatory Affairs Group LLC, United States
 Murray M. Lumpkin, MD,MSc (SCHAGY), Senior Fellow, Bill and Melinda Gates Foundation, United States
SPEAKER (S):
 Margaret A. Hamburg, MD (SPKAGY), Commissioner, FDA, United States
Emer Cooke, MBA (SPKAGY), Head of International and European Cooperation, European Medicines Agency, European Union, United Kingdom
Paul Glover, MBA (SPKAGY), Assistant Deputy Minister of the Health Products and Food Branch, Health Canada, Canada
Description
In this session, the audience will hear views from the leaders of three of the most influential drug regulatory agencies - The Health Products and Food Branch of Health Canada, the European Medicines Agency and the US FDA - on important issues.